Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 900 | 1,220 | 2,470 | 2,340 | 3,018 |
| TOTAL | $900 | $1,220 | $2,470 | $2,340 | $3,018 |
| Non-Current Assets | |||||
| PPE Net | N/A | 6,660 | 14,830 | N/A | 20,376 |
| Investments And Advances | 0 | 0 | 6,180 | 1,900 | 6,351 |
| Other Non-Current Assets | 990 | 1,230 | 460 | 16,540 | 18,160 |
| TOTAL | $990 | $7,890 | $21,470 | $18,440 | $44,887 |
| Total Assets | $1,890 | $9,110 | $23,940 | $20,780 | $47,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,410 | 2,620 | 4,200 | 5,430 | 5,957 |
| Accrued Expenses | 8,660 | 11,610 | 12,780 | 13,060 | 13,335 |
| Other current liabilities | 11,800 | 12,700 | 17,160 | 14,810 | 15,557 |
| TOTAL | $22,870 | $26,930 | $34,140 | $33,300 | $34,849 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,280 | 0 | 3,130 | 3,606 |
| TOTAL | $2,900 | $5,830 | $1,690 | $4,730 | $4,796 |
| Total Liabilities | $25,770 | $32,760 | $35,830 | $38,030 | $39,645 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 14 |
| Other shareholders' equity | 350 | 500 | -10 | -20 | 240 |
| TOTAL | $77,110 | $76,960 | $74,560 | $74,700 | $73,876 |
| Total Liabilities And Equity | $102,880 | $109,720 | $110,390 | $112,730 | $113,521 |